The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

The Psychological Services department at OSF Saint Anthony’s Health Center in Alton will host a “lunch & learn” program to ...

Striving to stay sober, Hal Pyzyna succeeded for nearly a decade until the COVID-19 pandemic struck in 2020 — the stress ...

More than 5 million Americans struggle with opioid use disorder, a physical addiction entwined with America’s health crisis, ...

A recent study published in JAMA Psychiatry has uncovered promising evidence suggesting that glucagon-like peptide-1 (GLP-1) ...

Hayes is one of millions of Americans who suffer from long COVID. Depending on the patient, the condition can rob someone of ...

ALTON According to the National Institute on Drug Abuse, abundant evidence shows that medications such as methadone, ...

A literature search identified more than a dozen published reports on the use of pure opioid antagonists (naloxone, naltrexone, methylnaltrexone) for the management of OIP in pediatric and adult ...

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...

“Locally, we’ve seen a decrease in overdose deaths and a lot of that is related to improved access to medications,” said ...

Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.

Thinking about giving up drinking for a brief period of time? Here are the mental and physical changes you can expect.